MoneyWorks4Me

Dr Lalchandani Labs informs about disclosures

12 Mar 2025 Evaluate
Dr Lalchandani Labs has informed that the Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Arjan Lalchandani.

The above information is a part of company’s filings submitted to BSE.

Peers